RPL17 and cancer: Tumor-intrinsic PD-1 is also expressed in a subset of PDL-1+ cells in a broad range of cancer types; the two act in cis (when present on the same cancer cell) and suppress cancer cell proliferation in vitro in the absence of adaptive immunity.